This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2.DG Altman , KF Schulz , D Moher , The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663–694.
3.D. Atkins Creating and synthesizing evidence with decision makers in mind: integrating evidence from clinical trials and other study designs. Med Care. 2007;45 (Suppl 2):S16–S22.
4.AW Chan , A Hrobjartsson , MT Haahr , Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291:2457–2465.
5.JC Dumville , DJ Torgerson , CE Hewitt . Reporting attrition in randomized controlled trials. BMJ. 2006;332:969–971.
6.M Ethgen , I Boutron , G Baron , Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic disease. Ann Intern Med. 2005;143:20–25.
7.M Fortin , J Dionne , G Pinho , Randomized controlled trials: do they have external validity for patients with multiple comorbidities? Ann Fam Med. 2006;4:104–108.
9.G Gartlehner , RA Hansen , D Nissman , A simple and valid tool distinguished efficacy from effectiveness studies. J Clin Epidemiol. 2006;59:1040–1048.
11.M Godwin , L Ruhland , I Casson , Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol. 2003;3:28.
12.CP Gross , R Mallory , A Heiat , Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med. 2002;137:10–16.
15.B Haynes . Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ. 1999;319:652–653.
16.L Hazell , SA Shakir . Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385–396.
17.C Hewitt , S Hahn , DJ Torgerson , Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ. 2005;330:1057–1058.
18.K Huwiler-Muntener , P Juni , C Junker , Quality of reporting of randomized trials as a measure of methodological quality. JAMA. 2002;287:2801–2804.
19.JP Ioannidis , SJ Evans , PC Gotzsche , Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141:781–788.
21.A Malmivaara , BW Koes , LM Bouter , Applicability and clinical relevance of results in randomized controlled trials: the Cochrane review on exercise therapy for low back pain as an example. Spine. 2006;31:1405–1409.
23.D Moher , KF Schulz , D Altman . The CONSORT Statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY). 2005;1:40–45.
24.M Mullner , H Matthews , DG Altman . Reporting on statistical methods to adjust for confounding: a cross-sectional survey. Ann Intern Med. 2002;136:122–126.
25.CD Mulrow . Rationale for systematic reviews. BMJ. 1994;309:597–599.
28.D Schwartz , J Lellouch . Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis. 1967;20:637–648.
30.T Sokka , T Pincus . Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum. 2003;48:313–318.
31.M Zwarenstein , S Treweek , JJ Gagnier , Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337:a2390.